Is Appen’s swing back to profitability a genuine turnaround, or one fast-growing region covering for a shrinking core business? The numbers Appen presented on August 27, 2026 answer that cleanly: it’s the latter. Group revenue rose 17.5% to US$119.9 million in H1 FY26, but Appen China alone grew 80.4% to US$76.2 million on generative-AI project work, while Appen Global — the legacy business serving Western enterprise clients — fell 26.9% to US$43.7 million and still posted a US$4.5 million underlying EBITDA loss.
That split matters more than the headline growth figure. Group gross margin actually slipped 30 basis points to 36.7%, which Appen attributes to China work carrying structurally lower margins than the rest of the business — meaning the segment driving Appen’s growth is also the one compressing its profitability per dollar of revenue.
Appen’s US$5.3 million swing to positive EBITDA is a China-generative-AI story wearing a company-wide turnaround headline.
The strain in Global tracks with what AIMultiple’s data-collection vendor comparison has flagged independently: Appen, it notes, has faced “a significant decline in customer satisfaction and financial stability” that has “impacted its services” and cost it customers. That’s not a data point Appen’s own presentation volunteers, but it’s consistent with a Global segment still bleeding EBITDA and management now targeting roughly US$12 million in additional cost cuts — 70% of which won’t even land until later in FY26 or Q1 FY27. Excluding its largest client, Global’s Q2 revenue did grow 65% quarter-on-quarter, a detail worth tracking as a sign of diversification beyond legacy relationships, but it’s a low base coming off steep prior losses.
For the data-labeling and RLHF market broadly, Appen’s split is a useful proxy: demand tied directly to generative-AI training pipelines is growing fast and cheap to source in China, while traditional Western annotation work — the business Appen built its name on — keeps eroding. Watch whether Appen’s China run-rate, now above US$175 million annualized, can sustain margin discipline as competitors like Surge AI and Scale AI chase the same generative-AI labeling demand, and whether the promised US$12 million in Global efficiencies actually stops the bleeding rather than just slowing it.
Appen (ASX:APX) FY26 Half-Year Update: AI Data Services Remain Central to Strategy Kalkine
— Kalkine
